← Back to Search
Pembrolizumab In Patients With Programmed Death Ligand 1–positive Advanced Ovarian Cancer: Analysis Of KEYNOTE-028
Andrea Varga, Sarina Piha-Paul, Patrick A. Ott, Janice M. Mehnert, Dominique Berton-Rigaud, Anne Morosky, Ping Yang, Jane Ruman, Daniela Matei